Invention Grant
- Patent Title: Recombinant clostridial neurotoxins with increased duration of effect
-
Application No.: US16707827Application Date: 2019-12-09
-
Publication No.: US11357821B2Publication Date: 2022-06-14
- Inventor: Juergen Frevert , Fred Hofmann , Michael Schmidt , Manuela López De La Paz , Daniel Scheps
- Applicant: Merz Pharma GmbH & Co. KGAA
- Applicant Address: DE Frankfurt am Main
- Assignee: Merz Pharma GmbH & Co. KGAA
- Current Assignee: Merz Pharma GmbH & Co. KGAA
- Current Assignee Address: DE Frankfurt am Main
- Agency: McBee Moore & Vanik IP, LLC
- Priority: EP15001733 20150611
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/33 ; C12N15/52 ; C12N15/70 ; A61K38/00

Abstract:
This invention relates to novel recombinant clostridial neurotoxins exhibiting increased duration of effect and to methods for the manufacture of such recombinant clostridial neurotoxins. These novel recombinant clostridial neurotoxins comprise a random coil domain, and the methods comprise the steps of inserting a nucleic acid sequence coding for a random coil domain into a nucleic acid sequence coding for a parental clostridial neurotoxin and expression of the recombinant nucleic acid sequence comprising the random coil domain-coding sequence in a host cell. The invention further relates to novel recombinant single-chain precursor clostridial neurotoxins used in such methods, nucleic acid sequences encoding such recombinant single-chain precursor clostridial neurotoxins, and pharmaceutical compositions comprising the recombinant clostridial neurotoxin with increased duration of effect.
Information query
IPC分类: